FR2666585B1 - Nouveaux pregnadiene-1,4 dione-3,20 acetal-16-17 esters-21, procede pour leur fabrication, compositions, et methodes pour le traitement des etats inflammatoires. - Google Patents
Nouveaux pregnadiene-1,4 dione-3,20 acetal-16-17 esters-21, procede pour leur fabrication, compositions, et methodes pour le traitement des etats inflammatoires.Info
- Publication number
- FR2666585B1 FR2666585B1 FR919110682A FR9110682A FR2666585B1 FR 2666585 B1 FR2666585 B1 FR 2666585B1 FR 919110682 A FR919110682 A FR 919110682A FR 9110682 A FR9110682 A FR 9110682A FR 2666585 B1 FR2666585 B1 FR 2666585B1
- Authority
- FR
- France
- Prior art keywords
- pregnadiene
- dione
- acetal
- esters
- compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
- C07J5/0092—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by an OH group free esterified or etherified
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/0026—Oxygen-containing hetero ring cyclic ketals
- C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US57894290A | 1990-09-07 | 1990-09-07 |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2666585A1 FR2666585A1 (fr) | 1992-03-13 |
FR2666585B1 true FR2666585B1 (fr) | 1994-09-09 |
Family
ID=24314964
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR919110682A Expired - Lifetime FR2666585B1 (fr) | 1990-09-07 | 1991-08-28 | Nouveaux pregnadiene-1,4 dione-3,20 acetal-16-17 esters-21, procede pour leur fabrication, compositions, et methodes pour le traitement des etats inflammatoires. |
Country Status (19)
Country | Link |
---|---|
US (1) | US5482934A (fr) |
JP (1) | JP3292928B2 (fr) |
KR (1) | KR100193085B1 (fr) |
AT (1) | AT402930B (fr) |
AU (1) | AU649472B2 (fr) |
BE (1) | BE1005876A5 (fr) |
BR (1) | BR1100860A (fr) |
CA (1) | CA2050812C (fr) |
CH (1) | CH683343A5 (fr) |
DE (2) | DE122005000030I2 (fr) |
ES (1) | ES2034893B1 (fr) |
FR (1) | FR2666585B1 (fr) |
GB (1) | GB2247680B (fr) |
GR (1) | GR1001529B (fr) |
HK (1) | HK1005881A1 (fr) |
IT (1) | IT1251376B (fr) |
LU (2) | LU88001A1 (fr) |
NL (2) | NL194917C (fr) |
PT (1) | PT98897B (fr) |
Families Citing this family (99)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW197380B (fr) * | 1990-03-02 | 1993-01-01 | Glaxo Group Ltd | |
US6536427B2 (en) | 1990-03-02 | 2003-03-25 | Glaxo Group Limited | Inhalation device |
SK280967B6 (sk) | 1990-03-02 | 2000-10-09 | Glaxo Group Limited | Inhalačný prístroj |
NZ265054A (en) * | 1993-04-02 | 1997-08-22 | Byk Gulden Lomberg Chem Fab | 16-hydroxy prednisolone cyclohexanecarboxaldehyde acetal derivatives |
ES2154725T3 (es) * | 1994-03-09 | 2001-04-16 | Byk Gulden Lomberg Chem Fab | Nuevos compuestos de sililo y su utilizacion. |
DE19635498A1 (de) * | 1996-09-03 | 1998-03-26 | Byk Gulden Lomberg Chem Fab | Verfahren zur Epimerenanreicherung |
SE9604751D0 (sv) * | 1996-12-20 | 1996-12-20 | Astra Ab | New therapy |
US6120752A (en) * | 1997-05-21 | 2000-09-19 | 3M Innovative Properties Company | Medicinal aerosol products containing formulations of ciclesonide and related steroids |
US6264923B1 (en) | 1998-05-13 | 2001-07-24 | 3M Innovative Properties Company | Medicinal aerosol formulation of ciclesonide and related compounds |
US6217895B1 (en) * | 1999-03-22 | 2001-04-17 | Control Delivery Systems | Method for treating and/or preventing retinal diseases with sustained release corticosteroids |
US20040121014A1 (en) * | 1999-03-22 | 2004-06-24 | Control Delivery Systems, Inc. | Method for treating and/or preventing retinal diseases with sustained release corticosteroids |
US6375972B1 (en) | 2000-04-26 | 2002-04-23 | Control Delivery Systems, Inc. | Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
AR028948A1 (es) | 2000-06-20 | 2003-05-28 | Astrazeneca Ab | Compuestos novedosos |
WO2003079972A2 (fr) | 2002-02-22 | 2003-10-02 | New River Parmaceuticals Inc. | Systemes de distribution d'agents actifs et methodes de protection et d'administration d'agents actifs |
US7468433B2 (en) | 2000-11-10 | 2008-12-23 | Nycomed Gmbh | Process for the production of 16,17-[(cyclohexylmethylen)bis(oxy)]-11,21-dihydroxy-pregna-1,4-dien-3,20-dion or its 21-isobutyrat by transketalisation |
DE10055820C1 (de) * | 2000-11-10 | 2002-07-25 | Byk Gulden Lomberg Chem Fab | Verfahren zur Herstellung eines Glucocorticoids |
ITMI20020148A1 (it) * | 2002-01-29 | 2003-07-29 | Nicox Sa | Nuovi corticosteroidi |
US8871241B2 (en) | 2002-05-07 | 2014-10-28 | Psivida Us, Inc. | Injectable sustained release delivery devices |
PL373433A1 (en) * | 2002-08-30 | 2005-08-22 | Altana Pharma Ag | The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis |
WO2004033478A2 (fr) * | 2002-10-08 | 2004-04-22 | Sepracor Inc. | Formes modifiees par l'acide gras des glucocorticoides |
ATE405275T1 (de) | 2002-12-12 | 2008-09-15 | Nycomed Gmbh | Kombinationsarzneimittel aus r,r-formoterol und ciclesonide |
CN100404545C (zh) * | 2003-03-27 | 2008-07-23 | 尼科梅德有限责任公司 | 具有规定粒径的结晶环缩松的制备方法 |
MY143936A (en) | 2003-03-27 | 2011-07-29 | Nycomed Gmbh | Process for preparing crystalline ciclesonide with defined particle size |
GB0312148D0 (en) | 2003-05-28 | 2003-07-02 | Aventis Pharma Ltd | Stabilized pharmaceutical products |
CA2528479A1 (fr) | 2003-06-13 | 2004-12-23 | Altana Pharma Ag | Combinaison de formoterol et de ciclesonide |
GB0315889D0 (en) * | 2003-07-08 | 2003-08-13 | Aventis Pharma Ltd | Stable pharmaceutical products |
BRPI0413330A (pt) * | 2003-08-29 | 2006-10-10 | Ranbaxy Lab Ltd | inibidores de fosfodiesterase do tipo iv, composição farmacêutica contendo os mesmos e processo para sua preparação |
ATE476185T1 (de) * | 2003-09-15 | 2010-08-15 | Nycomed Gmbh | Verwendung von ciclesonid zur behandlung von entzündlichen darmerkrankungen |
CA2538419C (fr) * | 2003-09-16 | 2012-07-03 | Altana Pharma Ag | Utilisation de ciclesonide dans le traitement de maladies respiratoires |
WO2005051931A2 (fr) * | 2003-11-26 | 2005-06-09 | Ranbaxy Laboratories Limited | Inhibiteurs de la phosphodiestérase |
PE20050941A1 (es) | 2003-12-16 | 2005-11-08 | Nycomed Gmbh | Suspensiones acuosas de ciclesonida para nebulizacion |
WO2005102354A1 (fr) * | 2004-04-20 | 2005-11-03 | Altana Pharma Ag | Utilisation de ciclesonide pour le traitement des maladies respiratoires chez des patients fumeurs |
CN100338089C (zh) * | 2004-08-12 | 2007-09-19 | 重庆医药工业研究院有限责任公司 | 一种哮喘病治疗药物环索奈德的新的制备方法 |
EP1796679A1 (fr) * | 2004-09-10 | 2007-06-20 | Altana Pharma AG | Combinaison de ciclesonide et d'inhibiteur de syk et procedes d'utilisation |
CN100345864C (zh) * | 2004-10-29 | 2007-10-31 | 天津药业研究院有限公司 | 一种治疗呼吸道疾病的甾体药物的制备方法及其中间体 |
ES2265276B1 (es) | 2005-05-20 | 2008-02-01 | Laboratorios Almirall S.A. | Derivados de 4-(2-amino-1-hidroxietil)fenol como agonistas del receptor beta2 adrenergico. |
AU2006259604A1 (en) * | 2005-06-14 | 2006-12-28 | Gilead Sciences, Inc. | Substituted phenylphosphates as mutual prodrugs of steroids and beta -agonists for the treatment of pulmonary inflammation and bronchoconstriction |
CN1325508C (zh) * | 2005-06-21 | 2007-07-11 | 浙江仙琚制药股份有限公司 | 一锅法制备泼尼松龙衍生物 |
TW200738634A (en) | 2005-08-02 | 2007-10-16 | Astrazeneca Ab | New salt |
NZ566128A (en) * | 2005-09-02 | 2011-03-31 | Nicox Sa | Nitrooxy derivatives of glucocorticoids |
EP1934219A1 (fr) | 2005-09-16 | 2008-06-25 | Ranbaxy Laboratories Limited | Pyrazolo[3,4-b]pyridines substituees en tant qu'inhibiteurs de la phosphodiesterase |
RU2008119323A (ru) | 2005-10-19 | 2009-11-27 | Рэнбакси Лабораториз Лимитед (In) | Фармацевтические композиции мускаринового рецептора |
WO2007045980A1 (fr) * | 2005-10-19 | 2007-04-26 | Ranbaxy Laboratories Limited | Compositions d'inhibiteurs de la phosphodiesterase de type iv |
WO2007056181A2 (fr) * | 2005-11-02 | 2007-05-18 | Sicor, Inc. | Procede perfectionne destine a la preparation de ciclesonide |
WO2007092574A2 (fr) * | 2006-02-08 | 2007-08-16 | Sicor, Inc. | Formes cristallines de ciclesonide |
US20070232578A1 (en) * | 2006-02-15 | 2007-10-04 | Pierluigi Rossetto | Crystalline forms of ciclesonide |
ES2296516B1 (es) * | 2006-04-27 | 2009-04-01 | Laboratorios Almirall S.A. | Derivados de 4-(2-amino-1-hidroxietil)fenol como agonistas del receptor beta2 adrenergico. |
WO2008015696A2 (fr) * | 2006-05-23 | 2008-02-07 | Cadila Healthcare Limited | Procédé pour préparer le ciclésonide |
WO2008010765A1 (fr) | 2006-07-19 | 2008-01-24 | Astrazeneca Ab | Nouveaux composés |
EP2474531A3 (fr) * | 2006-08-22 | 2013-12-04 | Ranbaxy Laboratories Limited | Inhibiteurs de métalloprotéase de matrice |
WO2008062450A2 (fr) * | 2006-09-18 | 2008-05-29 | Cadila Healthcare Limited | Polymorphes cristallins de ciclésonide |
AU2007298770B2 (en) | 2006-09-19 | 2013-01-31 | Cipla Limited | Processes for the preparation of ciclesonide and its crystal form |
US20110021473A1 (en) * | 2006-09-22 | 2011-01-27 | Ranbaxy Laboratories Limited | Inhibitors of phosphodiesterase type-iv |
US20100029728A1 (en) * | 2006-09-22 | 2010-02-04 | Ranbaxy Laboratories Limited | Phosphodiesterase inhibitors |
ES2302447B1 (es) * | 2006-10-20 | 2009-06-12 | Laboratorios Almirall S.A. | Derivados de 4-(2-amino-1-hidroxietil)fenol como agonistas del receptor beta2 adrenergico. |
TW200825084A (en) | 2006-11-14 | 2008-06-16 | Astrazeneca Ab | New compounds 521 |
ES2385681T3 (es) | 2006-12-19 | 2012-07-30 | Astrazeneca Ab | Derivados de quinuclidinol como antagonistas de receptores muscarínicos |
ES2306595B1 (es) * | 2007-02-09 | 2009-09-11 | Laboratorios Almirall S.A. | Sal de napadisilato de 5-(2-((6-(2,2-difluoro-2-feniletoxi)hexil)amino)-1-hidroxietil)-8-hidroxiquinolin-2(1h)-ona como agonista del receptor adrenergico beta2. |
EP1958947A1 (fr) | 2007-02-15 | 2008-08-20 | Ranbaxy Laboratories Limited | Inhibiteurs de la phosphodiestérase de type 4 |
NZ579645A (en) * | 2007-03-14 | 2012-01-12 | Ranbaxy Lab Ltd | Pyrazolo (3, 4-b) pyridine derivatives as phosphodiesterase inhibitors |
EP2124943A1 (fr) * | 2007-03-14 | 2009-12-02 | Ranbaxy Laboratories Limited | Dérivés de pyrazolo[3,4-b]pyridine comme inhibiteurs de phosphodiestérases |
EP2022796A1 (fr) * | 2007-08-07 | 2009-02-11 | Nycomed GmbH | Ciclésonide amorphe |
US20090075959A1 (en) * | 2007-09-19 | 2009-03-19 | Protia, Llc | Deuterium-enriched ciclesonide |
ES2320961B1 (es) * | 2007-11-28 | 2010-03-17 | Laboratorios Almirall, S.A. | Derivados de 4-(2-amino-1-hidroxietil)fenol como agonistas del receptor adrenergico beta2. |
EP2096105A1 (fr) * | 2008-02-28 | 2009-09-02 | Laboratorios Almirall, S.A. | Dérivés de 4-(2-amino-1-hydroxyethyl)phénol en tant qu'antagonistes du récepteur adrénergique b2 |
CA2714653A1 (fr) * | 2008-03-13 | 2009-09-17 | Farmabios S.P.A. | Procede pour la preparation de derives de pregnane |
EP2111861A1 (fr) | 2008-04-21 | 2009-10-28 | Ranbaxy Laboratories Limited | Compositions d'inhibiteurs de type IV de la phosphodiestérase |
BRPI0912657A2 (pt) * | 2008-05-13 | 2016-01-26 | Astrazeneca Ab | produto farmacêutico compreendendo um antagonista de receptor muscarínico e um agonista beta2-adrenorreceptor |
BRPI0822693A2 (pt) | 2008-05-13 | 2015-07-07 | Astrazeneca Ab | Derivados de quinuclidina como antagonistas do receptor muscarínico m3 |
WO2009144494A1 (fr) | 2008-05-27 | 2009-12-03 | Astrazeneca Ab | Dérivés de phénoxypyridinylamide et leur utilisation dans le traitement d'états pathologiques induits par la phosphodiésterase 4 (pde4) |
US20100120737A1 (en) * | 2008-11-10 | 2010-05-13 | Martin Feth | Amorphous ciclesonide |
WO2010067102A1 (fr) | 2008-12-09 | 2010-06-17 | Astrazeneca Ab | Dérivés de diazaspiro[5.5]undécane et composés associés utilisés comme antagonistes des récepteurs muscariniques et agonistes des récepteurs bêta adrénergiques dans le traitement des affections pulmonaires |
UY32297A (es) | 2008-12-22 | 2010-05-31 | Almirall Sa | Sal mesilato de 5-(2-{[6-(2,2-difluoro-2-fenilitoxi) hexil]amino}-1-hidroxietil)-8-hidroxiquinolin-2( 1h)-ona como agonista del receptor b(beta)2 acrenérgico |
ES2471145T3 (es) | 2009-03-09 | 2014-06-25 | Mikasa Seiyaku Co,. Ltd. | Compuesto esteroide |
EP2228368A1 (fr) | 2009-03-12 | 2010-09-15 | Almirall, S.A. | Procédé de fabrication de 5-(2-{[6-(2,2-difluoro-2-ph2nyl2thoxy)hexyl]amino}-1-hydroxy2thyl)-8-hydroxyquinolin-2(1h)-one |
ES2683864T3 (es) | 2009-10-01 | 2018-09-28 | Adare Pharmaceuticals, Inc. | Composiciones de corticosteroides administradas oralmente |
GB0918922D0 (en) | 2009-10-28 | 2009-12-16 | Vantia Ltd | Aminopyridine derivatives |
GB0918923D0 (en) | 2009-10-28 | 2009-12-16 | Vantia Ltd | Aminothiazole derivatives |
GB0918924D0 (en) | 2009-10-28 | 2009-12-16 | Vantia Ltd | Azaindole derivatives |
JP2013515741A (ja) * | 2009-12-23 | 2013-05-09 | サイヴィーダ ユーエス,インコーポレイテッド | 持続放出性送達デバイス |
WO2011093814A2 (fr) | 2010-01-29 | 2011-08-04 | Mahmut Bilgic | Compositions pharmaceutiques combinées comprenant du formotérol et du ciclésonide |
WO2011136752A1 (fr) | 2010-04-26 | 2011-11-03 | Mahmut Bilgic | Composition pharmaceutique combinée comprenant du carmotérol et du ciclésonide pour le traitement de maladies respiratoires |
CN102477064B (zh) * | 2010-11-23 | 2014-06-11 | 天津金耀集团有限公司 | 一种制备环索奈德的16,17缩酮中间体 |
AU2012296880A1 (en) | 2011-08-18 | 2014-03-27 | Astrazeneca Ab | Pharmaceutical aerosol product for administration by oral or nasal inhalation |
EP2578570A1 (fr) | 2011-10-07 | 2013-04-10 | Almirall, S.A. | Nouveau procédé de fabrication de 5-(2-{[6-(2,2-difluoro-2-phényléthoxy)hexyl]amino}-1-hydroxyéthyl)-8-hydroxyquinolin-2(1h)-one via de nouveaux intermédiaires de synthèse |
WO2013109212A1 (fr) | 2012-01-16 | 2013-07-25 | Mahmut Bilgic | Formulations en poudre sèche comprenant de la ciclésonide |
US9109005B2 (en) | 2012-02-23 | 2015-08-18 | Boehringer Ingelheim International Gmbh | Method for manufacturing of ciclesonide |
EP2641900A1 (fr) | 2012-03-20 | 2013-09-25 | Almirall, S.A. | Nouvelles formes polymorphes de héminapadisylate de 5-(2-{[6-(2,2-difluoro-2-phényléthoxy) hexyl]amino}-1-(R)-hydroxyéthyl)-8-hydroxyquinolin-2(1h)-one en tant qu'agoniste du récepteur adrénergique ß2 |
WO2014007770A2 (fr) | 2012-07-05 | 2014-01-09 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Compositions d'inhalation comprenant un corticostéroïde et du sorbitol |
WO2014007772A2 (fr) | 2012-07-05 | 2014-01-09 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Compositions d'inhalation contenant du glucose anhydre |
WO2014007771A2 (fr) | 2012-07-05 | 2014-01-09 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Compositions d'inhalation comprenant un antagoniste du récepteur muscarinique |
WO2014007781A2 (fr) | 2012-07-05 | 2014-01-09 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Compositions d'inhalation |
WO2015034678A2 (fr) | 2013-09-06 | 2015-03-12 | Aptalis Pharmatech, Inc. | Corticostéroïde contenant des compositions de comprimés se désintégrant par voie orale pour œsophagite à éonisophiles |
US10233210B2 (en) | 2015-01-30 | 2019-03-19 | Coral Drugs Pvt. Ltd. | Process for preparation of glucocorticoid steroids |
TWI728172B (zh) | 2016-08-18 | 2021-05-21 | 美商愛戴爾製藥股份有限公司 | 治療嗜伊紅性食道炎之方法 |
CN106749493A (zh) * | 2017-01-09 | 2017-05-31 | 河南利华制药有限公司 | 一种哈西奈德中间体的制备工艺 |
AU2019287541A1 (en) | 2018-06-14 | 2021-01-21 | Astrazeneca Uk Limited | Methods for treating and preventing symptoms of asthma with a corticosteroid pharmaceutical composition |
US20230218644A1 (en) | 2020-04-16 | 2023-07-13 | Som Innovation Biotech, S.A. | Compounds for use in the treatment of viral infections by respiratory syndrome-related coronavirus |
WO2024020164A2 (fr) * | 2022-07-21 | 2024-01-25 | Firefly Bio, Inc. | Agonistes du récepteur des glucocorticoïdes et leurs conjugués |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3197469A (en) * | 1958-08-06 | 1965-07-27 | Pharmaceutical Res Products In | 16, 17-acetals and ketals of 6-halo-16, 17-dihydroxy steroids of the pregnane seriesand intermediates therefor |
US3079384A (en) * | 1960-10-10 | 1963-02-26 | Olin Mathieson | C-ring substituted 6alpha-halo steroids and process for producing them |
SE378109B (fr) * | 1972-05-19 | 1975-08-18 | Bofors Ab | |
US3992534A (en) * | 1972-05-19 | 1976-11-16 | Ab Bofors | Compositions and method of treating with component B of stereoisomeric mixtures of 2'-unsymmetrical 16,17-methylenedioxy steriods |
SE378110B (fr) * | 1972-05-19 | 1975-08-18 | Bofors Ab | |
US4272446A (en) * | 1974-02-27 | 1981-06-09 | Pierrel S.P.A. | Steroids and process for preparing the same |
CH608244A5 (en) * | 1974-02-27 | 1978-12-29 | Pierrel Spa | Process for the preparation of steroids |
GB1504294A (en) * | 1974-03-05 | 1978-03-15 | Palladino G | 6 beta-fluoropregnane compounds |
NL7412537A (nl) * | 1974-05-17 | 1975-11-19 | Lark Spa | Werkwijze voor het bereiden van 16.17-cyclische acetalen en ketalen van 9-(alpha)-halogeensteroiden. |
US4036831A (en) * | 1975-10-28 | 1977-07-19 | Steroid Development Company Establishment | Trimethyl siloxane steroid intermediates |
DE3012888A1 (de) * | 1980-03-31 | 1981-10-08 | Schering Ag Berlin Und Bergkamen, 1000 Berlin | Neue steroide und verfahren zu ihrer herstellung |
SE8008524L (sv) * | 1980-12-04 | 1982-06-05 | Draco Ab | 4-pregnen-derivat, ett forfarande for deras framstellning, beredning och metod for behandling av inflammatoriska tillstand |
IT1196142B (it) * | 1984-06-11 | 1988-11-10 | Sicor Spa | Procedimento per la preparazione di 16,17-acetali di derivati pregnanici e nuovi composti ottenuti |
SE8604059D0 (sv) * | 1986-09-25 | 1986-09-25 | Astra Pharma Prod | A method of controlling the epimeric distribution in the preparation of 16,17-acetals of pregnane derivatives |
DE3640709A1 (de) * | 1986-11-28 | 1988-06-09 | Schering Ag | Verfahren zur herstellung von 6(alpha),9(alpha)-difluor-11ss,17(alpha)-dihydroxy-16(alpha)-methyl-4-pregnen-3,20-dion und dessen derivate |
-
1991
- 1991-08-13 GR GR910100353A patent/GR1001529B/el not_active IP Right Cessation
- 1991-08-28 IT ITMI912296A patent/IT1251376B/it active IP Right Grant
- 1991-08-28 FR FR919110682A patent/FR2666585B1/fr not_active Expired - Lifetime
- 1991-08-30 NL NL9101472A patent/NL194917C/nl not_active IP Right Cessation
- 1991-09-02 BE BE9100816A patent/BE1005876A5/nl not_active IP Right Cessation
- 1991-09-03 GB GB9118967A patent/GB2247680B/en not_active Expired - Lifetime
- 1991-09-04 LU LU88001A patent/LU88001A1/fr active Protection Beyond IP Right Term
- 1991-09-05 DE DE200512000030 patent/DE122005000030I2/de active Active
- 1991-09-05 DE DE4129535A patent/DE4129535C2/de not_active Expired - Lifetime
- 1991-09-05 ES ES9101991A patent/ES2034893B1/es not_active Expired - Fee Related
- 1991-09-06 AT AT0176991A patent/AT402930B/de not_active IP Right Cessation
- 1991-09-06 JP JP22741891A patent/JP3292928B2/ja not_active Expired - Lifetime
- 1991-09-06 CH CH2619/91A patent/CH683343A5/de not_active IP Right Cessation
- 1991-09-06 CA CA002050812A patent/CA2050812C/fr not_active Expired - Lifetime
- 1991-09-06 PT PT98897A patent/PT98897B/pt not_active IP Right Cessation
- 1991-09-06 AU AU83686/91A patent/AU649472B2/en not_active Expired
- 1991-09-07 KR KR1019910015617A patent/KR100193085B1/ko not_active IP Right Cessation
-
1994
- 1994-07-20 US US08/278,112 patent/US5482934A/en not_active Expired - Lifetime
-
1997
- 1997-05-14 BR BR1100860-1A patent/BR1100860A/pt active IP Right Grant
-
1998
- 1998-06-08 HK HK98105034A patent/HK1005881A1/xx not_active IP Right Cessation
-
2005
- 2005-06-02 NL NL300196C patent/NL300196I2/nl unknown
- 2005-11-09 LU LU91205C patent/LU91205I2/fr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2666585B1 (fr) | Nouveaux pregnadiene-1,4 dione-3,20 acetal-16-17 esters-21, procede pour leur fabrication, compositions, et methodes pour le traitement des etats inflammatoires. | |
FI820280L (fi) | Aromatiska heterocykliska estrar av steroider deras framstaellning och dessa innehaollande farmaceutiska blandningar | |
FR2565104B1 (fr) | Nouvelles preparations solides de nifedipine, utiles notamment comme agents vasodilatateurs, et procede pour leur fabrication | |
FR2508431B1 (fr) | Composition de traitement, son procede de fabrication et son utilisation pour le traitement des eaux d'egout | |
DE69004081T2 (de) | Verwendung der Stearidonsäure zur Behandlung von Entzündungserkrankungen. | |
RO77557A (fr) | Procede pour la preparation continue du 1,4-butandiol | |
MA18939A1 (fr) | Procede de preparation d'un agent pour le traitement de theilerioses | |
BE887544A (fr) | Procede de traitement de mattes sulfureuses | |
FR2636985B1 (fr) | Composition assouplissante et procede pour le traitement de textiles | |
FR2664585B1 (fr) | Structures refractaires refroidies et procede pour leur fabrication. | |
FR2657081B1 (fr) | Nouveaux derives d'arylvinylamide, leur procede de fabrication et leur application en therapeutique. | |
FR2665461B1 (fr) | Aciers non affines a tenacite elevee et procede pour leur fabrication. | |
FR2728142B1 (fr) | Composition pour le traitement anti-germinatif de tubercules ou de bulbes ; procede de traitement | |
FR2667884B3 (fr) | Element de construction et procede pour sa fabrication. | |
MA21849A1 (fr) | Procede de fabrication d'alkyl - ethoxy - carboxylates . | |
FR2658814B1 (fr) | Procede de fabrication du bisphenol-a. | |
FR2656549B1 (fr) | Procede pour la fabrication d'un coude et coude fabrique suivant ce procede. | |
BE883732A (fr) | Procede et equipement pour la fabrication d'articles par etirage, et articles ainsi produits | |
FR2713657B1 (fr) | Nouveaux vecteurs pour le traitement du sida. | |
FR2308628A1 (fr) | Nouvelles 4-amino-5-thione-1,2,4-triazines, leur procede de preparation et leur application comme herbicides | |
RO79428A2 (fr) | Composition medicamenteuse pour le traitement des dermatoses | |
BE889339A (fr) | 6-hydrazono-pyrido(2,1-b)quinazoline-11-ones et procede pour leur preparation | |
FR2681618B1 (fr) | Cóoeur de croisement perfectionne et procede pour sa fabrication. | |
FR2548884B3 (fr) | Nouveaux cintres pour vetements, et leur procede de fabrication | |
BE894544A (fr) | Compositions detergentes, unites de dosage qui les contiennent, procede pour leur fabrication et leur emploi |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
TP | Transmission of property | ||
TP | Transmission of property | ||
CP | Supplementary protection certificate (spc) filed |
Free format text: PRODUCT NAME: CICLESONIDE; NAT. REGISTRATION NO/DATE: NL 34299 20090223; FIRST REGISTRATION: GB - PL 20141/0004 20040416 Spc suppl protection certif: 09C0015 Filing date: 20090330 |
|
CD | Change of name or company name | ||
CR | Request for supplementary protection certificate laid open to the public (eec regulation of 18 june 1992) |
Free format text: PRODUCT NAME: CICLESONIDE; REGISTRATION NO/DATE IN FRANCE: NL 34299 DU 20090223; REGISTRATION NO/DATE AT EEC: PL 20141/0004 DU 20040416 Spc suppl protection certif: 09C0015 Filing date: 20090330 |
|
CP | Supplementary protection certificate (spc) filed | ||
AV | Other action affecting the existence or the validity of an industrial property right | ||
CY | Supplementary certificate of protection granted (eec regulation of 18 june 1992) |
Free format text: PRODUCT NAME: CICLESONIDE; REGISTRATION NO/DATE IN FRANCE: NL 34299 DU 20090223; REGISTRATION NO/DATE AT EEC: PL 20141/0004 DU 20040416 Spc suppl protection certif: 09C0015 Filing date: 20090330 Extension date: 20160827 |
|
SPCC | Change of owner's name or address for a supplementary protection certificate |
Owner name: TAKEDA GMBH, DE Free format text: PRODUCT NAME: CICLESONIDE; NAT. REGISTRATION NO/DATE: NL 34299 20090223; FIRST REGISTRATION: PL 20141/0004 20040416 Spc suppl protection certif: 09C0015 Filing date: 20090330 |
|
SPAY | Annual fee for spc paid |
Free format text: PRODUCT NAME: CICLESONIDE; NAT. REGISTRATION NO/DATE: NL 34299 20090223; FIRST REGISTRATION: GB - PL 20141/0004 20040416 Spc suppl protection certif: 09C0015 Filing date: 20090330 Year of fee payment: 5 Extension date: 20160827 |
|
SPCC | Change of owner's name or address for a supplementary protection certificate |
Owner name: TAKEDA GMBH, DE Free format text: PRODUCT NAME: CICLESONIDE; NAT. REGISTRATION NO/DATE: NL 34299 20090223; FIRST REGISTRATION: GB - PL 20141/0004 20040416 Spc suppl protection certif: 09C0015 Filing date: 20090330 Extension date: 20160827 |
|
SPCT | Total transmission of property of a supplementary protection certificate |
Owner name: TAKEDA GMBH, DE Free format text: PRODUCT NAME: CICLESONIDE; NAT. REGISTRATION NO/DATE: NL 34299 20090223; FIRST REGISTRATION: GB - PL 20141/0004 20040416 Spc suppl protection certif: 09C0015 Filing date: 20090330 Extension date: 20160827 |